Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04259008 · ClinicalTrials.gov registry record · Phase 4
Safety of Manganese Restriction in Neonatal Parenteral Nutrition
A Phase 4 study, sponsored by Sharp HealthCare.
- Completed
- Registry status
- Phase 4
- Development phase
- 26
- Enrollment target
NCT04259008: Completed Phase 4 study, sponsored by Sharp HealthCare.
NCT04259008 is a Phase 4 study that has completed, run by Sharp HealthCare. The registered enrollment target is 26 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04259008, a Phase 4 study, has completed, sponsored by Sharp HealthCare.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 26 participants
- Enrollment target
Study Summary
Participants will be \<= 32 weeks gestational age (GA) neonates randomized to parenteral nutrition (PN) prepared with standard dose trace elements or to PN prepared with standard trace elements minus manganese.
Primary Outcome
concentration of manganese in blood
Interventions
- OTHER Manganese omission
- OTHER 5 mCg/kg/day manganese from "Multitrace-4 Neonatal."
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-06-11 |
| Est. Completion | 2021-07-22 |
| Phase | Phase 4 |
What the finished NCT04259008 record still lists
NCT04259008 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Manganese omission is the first listed.
NCT04259008 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04259008 about?
NCT04259008 is a clinical study titled "Safety of Manganese Restriction in Neonatal Parenteral Nutrition". Participants will be \<= 32 weeks gestational age (GA) neonates randomized to parenteral nutrition (PN) prepared with standard dose trace elements or to PN prepared with standard trace elements minus manganese.
What is the current status of trial NCT04259008?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 26 participants. The study started on 2020-06-11. Estimated completion is 2021-07-22.
What interventions are being tested in trial NCT04259008?
The interventions under investigation include: Manganese omission (OTHER), 5 mCg/kg/day manganese from "Multitrace-4 Neonatal." (OTHER).
Who is sponsoring clinical trial NCT04259008?
This trial is sponsored by Sharp HealthCare, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04259008's enrollment target sits among peer trials
26 1655th of 2000 higher than 332 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI